Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-23
1999-11-09
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
059815523
ABSTRACT:
Sublingual and buccal dosage forms of droperidol are provided in a method for treating migraine using such formulations.
REFERENCES:
patent: 5122127 (1992-06-01), Stanley
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5310561 (1994-05-01), Jao et al.
Zhang et al., Pharmaceutical Research (New York), 14(11 Suppl.) S662 (abstract), 1997.
Steffens et al., Acta Anaesthesiologica 41 (Suppl. 110) 182 (abstract), 1997.
Wang, et al. Droperidol Treatment of Status Migrainosus and Refractory Migraine, Headache. Jun., 1997, pp. 377-382.
Wang, et al. Droperidol Treatment of Acute Refractory Migraine and Status Migrainosus, Headache, Apr., 1996, p. 280.
John F. Rothrock, MD., Treatment of Acute Migraine with Intravenous Droperidol, Headache, Apr. 1997, pp. 256-257.
Spivack Phyllis G.
Taylor Pharmaceuticals
LandOfFree
Sublingual and buccal compositions of droperidol and method for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sublingual and buccal compositions of droperidol and method for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual and buccal compositions of droperidol and method for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456457